{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:47:54Z","timestamp":1790117274380,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.numecd.2014.10.009","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T16:38:14Z","timestamp":1414859894000},"page":"230-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease"],"prefix":"10.1016","volume":"25","author":[{"given":"S.F.","family":"Bakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Tushuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"G\u00f6z\u00fctok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"\u00c7iftci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Gelderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2014.10.009_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.numecd.2013.04.004","article-title":"AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a \u201cglycoxidation-centric\u201d point of view","volume":"23","author":"Chilelli","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.10.009_bib2","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00125-009-1458-9","article-title":"Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications","volume":"52","author":"Bierhaus","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2014.10.009_bib3","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1073\/pnas.94.12.6474","article-title":"Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy","volume":"94","author":"Koschinsky","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2014.10.009_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1464-5491.2001.00498.x","article-title":"Coeliac disease and type 1 diabetes mellitus \u2013 the case for screening","volume":"18","author":"Holmes","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2014.10.009_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev-immunol-040210-092915","article-title":"Integration of genetic and immunological insights into a model of celiac disease pathogenesis","volume":"29","author":"Abadie","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.numecd.2014.10.009_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-009-1277-z","article-title":"Potential reno-protective effects of a gluten-free diet in type 1 diabetes","volume":"52","author":"Malalasekera","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2014.10.009_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00592-012-0395-0","article-title":"Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications","volume":"50","author":"Bakker","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2014.10.009_bib8","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.2337\/dc11-0149","article-title":"High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease","volume":"34","author":"Leeds","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.10.009_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.numecd.2013.09.005","article-title":"Potential coeliac disease in type 1 diabetes mellitus: does a positive antibody lead to increased complications?","volume":"24","author":"Leeds","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.10.009_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2337\/dc12-0766","article-title":"A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease","volume":"36","author":"Mollazadegan","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.10.009_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00592-011-0301-1","article-title":"Type 1 diabetes mellitus and celiac disease: endothelial dysfunction","volume":"50","author":"Picarelli","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2014.10.009_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.atherosclerosis.2011.04.042","article-title":"Combined atherogenic effects of celiac disease and type 1 diabetes mellitus","volume":"217","author":"Pitocco","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2014.10.009_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"Suppl. 1","key":"10.1016\/j.numecd.2014.10.009_bib14","first-page":"S11","article-title":"Standards of medical care in diabetes\u20132012","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.10.009_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2014.10.009_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2036.2009.04226.x","article-title":"Childhood coeliac disease: towards an improved serological mass screening strategy","volume":"31","author":"Hogen Esch","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.numecd.2014.10.009_bib17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1196\/annals.1333.036","article-title":"Simple noninvasive measurement of skin autofluorescence","volume":"1043","author":"Meerwaldt","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.numecd.2014.10.009_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dia.2009.0113","article-title":"Reference values of skin autofluorescence","volume":"12","author":"Koetsier","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.numecd.2014.10.009_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/dc06-1391","article-title":"Skin autofluorescence is a strong predictor of cardiac mortality in diabetes","volume":"30","author":"Meerwaldt","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2014.10.009_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/dme.12329","article-title":"Early elevation of albumin excretion rate is associated with poor gluten-free diet adherence in young people with coeliac disease and diabetes","volume":"31","author":"Pham-Short","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2014.10.009_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00592-012-0412-3","article-title":"Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update","volume":"50","author":"Piarulli","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2014.10.009_bib22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.numecd.2008.06.006","article-title":"Do advanced glycation end products contribute to the development of long-term diabetic complications?","volume":"18","author":"Pugliese","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2014.10.009_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00125-009-1263-5","volume":"52","author":"Nin","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2014.10.009_bib24","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00125-011-2186-5","article-title":"Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes","volume":"54","author":"Thomas","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2014.10.009_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/pedi.12028","article-title":"Coeliac disease, gluten-free diet and the development and progression of albuminuria in children with type 1 diabetes","volume":"14","author":"Gopee","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.numecd.2014.10.009_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/dia.2011.0043","article-title":"Increased accumulation of skin advanced glycation end products is associated with microvascular complications in type 1 diabetes","volume":"13","author":"Araszkiewicz","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.numecd.2014.10.009_bib27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00125-005-1828-x","article-title":"Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy","volume":"48","author":"Meerwaldt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2014.10.009_bib28","doi-asserted-by":"crossref","first-page":"15596","DOI":"10.1073\/pnas.242407999","article-title":"Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy","volume":"99","author":"Vlassara","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2014.10.009_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/dia.2007.0275","article-title":"Skin autofluorescence increases postprandially in human subjects","volume":"10","author":"Stirban","year":"2008","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.numecd.2014.10.009_bib30","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation end product accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314003172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475314003172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T02:23:30Z","timestamp":1538101410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475314003172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0939475314003172"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2014.10.009","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2014.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}